FDA to Review Easing Restrictions on Peptides

This summer the FDA will consider loosening restrictions on certain peptide injections, with encouragement from RFK Jr. and the Trump administration. Bloomberg Businessweek senior reporter Amanda Mull explains to hosts David Gura and Christina Ruffini how peptides are popular among wellness enthusiasts and biohackers, who claim they offer benefits ranging from treating tendonitis to enhancing tann

Source

Bloomberg Markets

Read full article at Bloomberg Markets

Opens original article in a new tab

Weekly Newsletter

The Daily Composite

Get the week's most revealing media bias comparisons, delivered every Monday morning.

Weekly. No spam. Unsubscribe anytime.

A Lindblad Expeditions Director Sold Nearly 53,000 Shares Worth $1.2 Million. Here's a Deeper Look at the Transaction.

35 minutes agoRead more →

EconomyDaily Composite

Yahoo Finance

With the Fed Holding Interest Rates Steady, Here's the Smartest Dividend Stock to Buy With $1,000 Right Now

about 1 hour agoRead more →

Bloomberg Markets

CRH Near Biggest-Ever Deal For Arcosa, Financial Times Says

Building materials group CRH Plc. is close to its biggest deal ever to acquire competitor Arcosa Inc., and an agreement could come as soon as next week, the Financial Times reports, citing people familiar with the matter.

about 1 hour agoRead more →

Forbes

Galaxy Z Fold 8 Release Date: Samsung Devices Get New Confirmation

Samsung's Galaxy Z Fold 8 Ultra, Z Flip 8 and Watch 9 series have been cleared for U.S. launch, confirming the July Unpacked release date is on track.

about 2 hours agoRead more →

The Daily Composite

Related Economy Stories

A Lindblad Expeditions Director Sold Nearly 53,000 Shares Worth $1.2 Million. Here's a Deeper Look at the Transaction.

With the Fed Holding Interest Rates Steady, Here's the Smartest Dividend Stock to Buy With $1,000 Right Now

CRH Near Biggest-Ever Deal For Arcosa, Financial Times Says

Galaxy Z Fold 8 Release Date: Samsung Devices Get New Confirmation